{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:59:32Z","timestamp":1790204372872,"version":"4.1.0"},"reference-count":14,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/eurheartj\/ehag602","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T11:23:13Z","timestamp":1786706593000},"source":"Crossref","is-referenced-by-count":0,"title":["Semaglutide mechanisms of action: the missing pieces"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4018-8533","authenticated-orcid":false,"given":"Subodh","family":"Verma","sequence":"first","affiliation":[{"name":"Division of Cardiac Surgery, Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital of Unity Health Toronto , Toronto M5B 1W8, Ontario ,","place":["Canada"]},{"name":"Department of Surgery, University of Toronto , Toronto, Ontario ,","place":["Canada"]},{"name":"Department of Pharmacology and Toxicology, University of Toronto , Toronto, Ontario ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz J","family":"Guzik","sequence":"additional","affiliation":[{"name":"Centre for Cardiovascular Science, Institute of Neuroscience and Cardiovascular Research, University of Edinburgh , Edinburgh ,","place":["UK"]},{"name":"Department of Internal and Agricultural Medicine, Jagiellonian University Medical College , Krakow ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6967-5685","authenticated-orcid":false,"given":"Francesco","family":"Cosentino","sequence":"additional","affiliation":[{"name":"Cardiology Unit, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"2026092318063006100_ehag602-B1","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1093\/eurheartj\/ehae744","article-title":"Pump, pipes, filter, sugar, weight, and more: the pluripotent prowess of semaglutide","volume":"46","author":"Verma","year":"2025","journal-title":"Eur Heart J"},{"key":"2026092318063006100_ehag602-B2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehag524","article-title":"Semaglutide and cardiovascular risk reduction: a mediation analysis of the SELECT trial","volume":"46","author":"Colhoun","year":"2026","journal-title":"Eur Heart J"},{"key":"2026092318063006100_ehag602-B3","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"2026092318063006100_ehag602-B4","doi-asserted-by":"publisher","first-page":"4828","DOI":"10.1002\/sim.8336","article-title":"Mediation analysis of time-to-event endpoints accounting for repeatedly measured mediators subject to time-varying confounding","volume":"38","author":"Vansteelandt","year":"2019","journal-title":"Stat Med"},{"key":"2026092318063006100_ehag602-B5","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1016\/S0140-6736(25)01375-3","article-title":"Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial","volume":"406","author":"Deanfield","year":"2025","journal-title":"Lancet"},{"key":"2026092318063006100_ehag602-B6","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/j.jacc.2024.08.007","article-title":"The effect of semaglutide on mortality and COVID-19-related deaths: an analysis from the SELECT trial","volume":"84","author":"Scirica","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026092318063006100_ehag602-B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101737","article-title":"Effects of once-weekly semaglutide 2.4\u2005mg on C-reactive protein in adults with overweight or obesity (STEP 1, 2, and 3): exploratory analyses of three randomised, double-blind, placebo-controlled, phase 3 trials","volume":"55","author":"Verma","year":"2023","journal-title":"EClinicalMedicine"},{"key":"2026092318063006100_ehag602-B8","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/j.jacc.2024.08.028","article-title":"Inflammation in obesity-related HFpEF: the STEP-HFpEF program","volume":"84","author":"Verma","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026092318063006100_ehag602-B9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI194748","article-title":"GLP-1 and the cardiovascular system","volume":"136","author":"Kahles","year":"2026","journal-title":"J Clin Invest"},{"key":"2026092318063006100_ehag602-B10","doi-asserted-by":"publisher","DOI":"10.1172\/JCI194751","article-title":"Antiinflammatory actions of glucagon-like peptide-1-based therapies beyond metabolic benefits","volume":"135","author":"Wong","year":"2025","journal-title":"J Clin Invest"},{"key":"2026092318063006100_ehag602-B11","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1093\/eurheartj\/ehaf690","article-title":"Semaglutide promotes bone marrow-derived progenitor cell flux towards an anti-inflammatory and pro-regenerative profile in high-risk patients: the SEMA-VR CardioLink-15 trial","volume":"47","author":"Park","year":"2026","journal-title":"Eur Heart J"},{"key":"2026092318063006100_ehag602-B12","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/S0140-6736(25)00509-4","article-title":"Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial","volume":"405","author":"Bonaca","year":"2025","journal-title":"Lancet"},{"key":"2026092318063006100_ehag602-B13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.126.327425","article-title":"Prevention of vascular aging as a novel paradigm for GLP-1 receptor agonist-mediated cardioprotection","volume":"139","author":"Dennis","year":"2026","journal-title":"Circ Res"},{"key":"2026092318063006100_ehag602-B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2026.04.044","article-title":"Comprehensive long-term changes in cardiovascular risk biomarkers with tirzepatide: a SURMOUNT-1 post hoc analysis","author":"Sattar","year":"2026","journal-title":"J Am Coll Cardiol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article-pdf\/doi\/10.1093\/eurheartj\/ehag602\/70786976\/ehag602.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article-pdf\/doi\/10.1093\/eurheartj\/ehag602\/70786976\/ehag602.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:06:40Z","timestamp":1790201200000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article\/doi\/10.1093\/eurheartj\/ehag602\/8770630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":14,"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehag602","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"article-number":"ehag602"}}